Piper Sandler Boosts Bausch Health Companies (NYSE:BHC) Price Target to $9.00

Bausch Health Companies (NYSE:BHC – Get Free Report) had its target price boosted by stock analysts at Piper Sandler from $7.00 to $9.00 in a research report issued to clients and investors on Monday, BayStreet.CA reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s price target points to a potential upside […]

Related Keywords

Canada ,United States ,Piper Sandler ,News Ratings For Bausch Health Companies Daily ,Royal Bank ,Jefferies Financial Group ,Segantii Capital Management Ltd ,Bausch Health Companies Price Performance ,Deutsche Bank ,Vanguard Group Inc ,Bausch Health Companies Inc ,Institutional Trading Of Bausch Health Companies ,Bausch Health Companies ,Get Free Report ,Financial Group ,Health Companies ,Bausch Health ,Asset Management ,Capital Management Ltd ,Health Companies Inc ,Bausch Health Companies Daily ,